ORTHOPEDIATRICS CORP
For the period ended Sep 30, 2025. Filed Oct 29, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Oct 29, 2025
KIDS$33.48-1.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders' Equity -
| Three and Nine Months Ended September 30, 2025 | ||||||
|---|---|---|---|---|---|---|
| Accumulated | ||||||
| Additional · Other · Total | ||||||
| Common Stock · Paid-in · Accumulated · Comprehensive · Stockholders' | ||||||
| Shares | Value | Capital | Deficit | Loss | Equity | |
| Balance at January 1, 2025 | 24,217,508 | $6 | $600,897 | $(235,564) | $(10,773) | $354,566 |
| Net loss | — | — | — | (10,659) | — | (10,659) |
| Other comprehensive loss | — | — | — | — | (853) | (853) |
| Restricted stock | 601,547 | — | 3,859 | — | — | 3,859 |
| Issuance of common stock | 8,922 | — | 233 | — | — | 233 |
| Balance at March 31, 2025 | 24,827,977 | $6 | $604,989 | $(246,223) | $(11,626) | $347,146 |
| Net loss | — | — | — | (7,113) | — | (7,113) |
| Other comprehensive gain | — | — | — | — | 6,680 | 6,680 |
| Restricted stock | 178,552 | — | 5,252 | — | — | 5,252 |
| Issuance of common stock | 55,143 | — | 1,261 | — | — | 1,261 |
| Stock portion of MedTech anniversary payment | 10,830 | — | 226 | — | — | 226 |
| Capital contribution associated with reclassification of MedTech liability to equity | — | — | 2,062 | — | — | 2,062 |
| Balance at June 30, 2025 | 25,072,502 | $6 | $613,790 | $(253,336) | $(4,946) | $355,514 |
| Net loss | — | — | — | (11,773) | — | (11,773) |
| Other comprehensive gain | — | — | — | — | 1,317 | 1,317 |
| Restricted stock | 4,828 | — | 4,251 | — | — | 4,251 |
| Balance at September 30, 2025 | 25,077,330 | $6 | $618,041 | $(265,109) | $(3,629) | $349,309 |
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
| Three and Nine Months Ended September 30, 2024 | ||||||
|---|---|---|---|---|---|---|
| Accumulated | ||||||
| Additional · Other · Total | ||||||
| Common Stock · Paid-in · Accumulated · Comprehensive · Stockholders' | ||||||
| Shares | Value | Capital | Deficit | Loss | Equity | |
| Balance at January 1, 2024 | 23,378,408 | $6 | $580,287 | $(197,742) | $(5,526) | $377,025 |
| Net loss | — | — | — | (7,805) | — | (7,805) |
| Other comprehensive loss | — | — | — | — | (1,435) | (1,435) |
| Restricted stock | 162,003 | — | 2,799 | — | — | 2,799 |
| Balance at March 31, 2024 | 23,540,411 | $6 | $583,086 | $(205,547) | $(6,961) | $370,584 |
| Net loss | — | — | — | (6,029) | — | (6,029) |
| Other comprehensive loss | — | — | — | — | (3,263) | (3,263) |
| Stock portion of MedTech anniversary payment | 4,288 | — | 133 | — | — | 133 |
| Stock portion of ApiFix anniversary installment | 245,812 | — | 6,929 | — | — | 6,929 |
| Restricted stock | 426,227 | — | 2,939 | — | — | 2,939 |
| Balance at June 30, 2024 | 24,216,738 | $6 | $593,087 | $(211,576) | $(10,224) | $371,293 |
| Net loss | — | — | — | (7,919) | — | (7,919) |
| Other comprehensive gain | — | — | — | — | 3,623 | 3,623 |
| Restricted stock | (2,692) | — | 3,922 | — | — | 3,922 |
| Balance at September 30, 2024 | 24,214,046 | $6 | $597,009 | $(219,495) | $(6,601) | $370,919 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.